English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/55592
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:


Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients

AuthorsSantamaría, Carlos; Muntión, Sandra; Rosón, Beatriz ; Blanco, Belén; López-Villar, Olga; Carrancio, Soraya; Sánchez-Guijo, Fermín M.; Díez-Campelo, María; Álvarez-Fernández, Stela ; Sarasquete, María Eugenia; De Las Rivas, Javier ; González, Marcos ; San Miguel, Jesús F. ; Cañizo, María Consuelo del
KeywordsMesenchymal stem cells
Myelodysplastic syndrome
Issue Date1-Aug-2012
PublisherFerrata Storti Foundation
CitationHaematologica 97(8): 1218-1224 (2012)
Abstract[Background]: Recent findings suggest that a specific deletion of Dicer1 in mesenchymal stromal cells-derived osteoprogenitors triggers several features of myelodysplastic syndrome in a murine model. Our aim was to analyze DICER1 and DROSHA gene and protein expression in mesenchymal stromal cells (the osteoblastic progenitors) obtained from bone marrow of myelodysplastic syndrome patients, in addition to microRNA expression profile and other target genes such as SBDS, a DICER1-related gene that promotes bone marrow dysfunction and myelodysplasia when repressed in a murine model. [Design and Methods]: Mesenchymal stromal cells from 33 bone marrow samples were evaluated. DICER, DROSHA and SBDS gene expression levels were assessed by real-time PCR and protein expression by Western blot. MicroRNA expresion profile was analyzed by commercial low-density arrays and some of these results were confirmed by individual real-time PCR. [Results]: Mesenchymal stromal cells from myelodysplastic syndrome patients showed lower DICER1 (0.65±0.08 vs. 1.91±0.57; P=0.011) and DROSHA (0.62±0.06 vs. 1.38±0.29; P=0.009) gene expression levels, two relevant endonucleases associated to microRNA biogenesis, in comparison to normal myelodysplastic syndrome. These findings were confirmed at protein levels by Western blot. Strikingly, no differences were observed between paired mononuclear cells from myelodysplastic syndrome and controls. In addition, mesenchymal stromal cells from myelodysplastic syndrome patients showed significant lower SBDS (0.63±0.06 vs. 1.15±0.28; P=0.021) gene expression levels than mesenchymal stromal cells from healthy controls. Furthermore, mesenchymal stromal cells from myelodysplastic syndrome patients showed an underlying microRNA repression compared to healthy controls. Real-time PCR approach confirmed that mir-155, miR-181a and miR- 222 were down-expressed in mesenchymal stromal cells from myelodysplastic syndrome patients. [Conclusions]: This is the first description of an impaired microRNA biogenesis in human mesenchymal stromal cells from myelodysplastic syndrome patients, where DICER1 and DROSHA gene and protein downregulation correlated to a gene and microRNA abnormal expression profile, validating the animal model results previously described.
DescriptionThis is an open-access paper.
Publisher version (URL)http://dx.doi.org/10.3324/haematol.2011.054437
Appears in Collections:(IBMCC) Artículos
Files in This Item:
File Description SizeFormat 
Impaired expression of DIC.pdf493,46 kBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.